Related Experiment Videos
How does one define progression of disease in patients with relapsing-remitting multiple sclerosis?
Archives of Neurology
|March 14, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Multiple Sclerosis Performance Test: validation of self-administered neuroperformance modules.
European journal of neurology·2020
Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
Multiple sclerosis (Houndmills, Basingstoke, England)·2015
Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon {beta}-1a.
Multiple sclerosis (Houndmills, Basingstoke, England)·2011
Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients.
Multiple sclerosis (Houndmills, Basingstoke, England)·2010
The hidden burden of depressive symptoms on functional autonomy in cognitive decline.
Neurodegenerative disease management·2026
Unraveling the protective effect of weekend catch-up sleep on overactive bladder risk.
Annals of medicine·2026
New pharmacological and biotechnological approaches for the treatment of neurotrophic keratopathy: From growth factors to gene therapy.
Indian journal of ophthalmology·2026
IL-12 Signaling Promotes Podocyte Senescence in Lupus Nephritis.
Arthritis & rheumatology (Hoboken, N.J.)·2026
Neurological disease progression in adults with ataxia telangiectasia: a longitudinal study.
Brain : a journal of neurology·2026
Diabetes and neurodegeneration in cognitively unimpaired older adults: implications for cognition.
Brain : a journal of neurology·2026